ArticleFrontiers in oncology2023

HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study.

Jiajie Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.